22:20 , Jan 5, 2018 |  BC Week In Review  |  Clinical News

BioSight reports Phase I/II data for AML candidate

BioSight Ltd. (Airport City, Israel) reported final data from 14 evaluable patients with newly diagnosed acute myelogenous leukemia (AML) in the Phase I/II BSTPHASE1-01 trial showing that BST-236 (astarabine) led to a median overall survival...
07:00 , May 23, 2016 |  BC Week In Review  |  Financial News

BioSight completes venture financing

BioSight Ltd. , Karmiel, Israel   Business: Cancer   Date completed: 2016-05-03   Type: Venture financing   Raised: Not disclosed   Investors: Arkin Holdings; Primera Capital; Michael Ilan Management; existing investors   Note: BioSight raised...
01:11 , May 17, 2016 |  BC Extra  |  Financial News

BioSight raises $13M

BioSight Ltd. (Karmiel, Israel) said it raised $13 million in a tranched venture financing co-led by Arkin Holdings and Primera Capital, each of which is to invest $5 million. Existing shareholders including Michael Ilan Management...